Deadline: May 05, 2014

Links Learn More about Peer Commentaries for JLB

Journal of Law and the Biosciences is pleased to solicit Peer Commentaries for the following articles:

Peer Commentaries provide experts in a specific field an opportunity to share their views on an article within that field that has been published in the journal. Commentators can provide critiques, different perspectives, and complementary materials. Peer Commentaries may be a maximum of 2,500 words including citations.

To apply for submission, commentators should first submit a short, 250-word summary of the proposed Peer Commentary here. Proposals should be submitted as manuscript type “Commentary”.  Proposals will then be evaluated, and a select number of authors will be asked to submit a full commentary for review. For more information about peer commentaries, click here.

Journal of Law and the Biosciences (JLB) is the first fully open access peer-reviewed legal journal focused on the advances at the intersection of law and the biosciences. A co-venture between Duke University, Harvard Law School, and Stanford University, and published by Oxford University Press, this open access, online, and interdisciplinary academic journal publishes cutting-edge scholarship in this important new field. JLB is published as one volume with three issues per year with new articles posted online on an ongoing basis.

JLB encourages the submission of original manuscripts, responses, essays, and new developments devoted to the examination of issues related to the intersection of law and biosciences, including bioethics, neuroethics, genetics, reproductive technologies, stem cells, enhancement, patent law, and food and drug regulation. The Journal welcomes submissions of varying length, with a theoretical, empirical, practical, or policy oriented focus. For more information about JLB, click here. To submit a manuscript, click hereJLB is actively soliciting articles for the next issue, which will be published on July 8, 2014.

bioethics enhancement genetics regulation reproductive technologies stem cells